SHORT Syndrome with Partial Lipodystrophy Due to Impaired Phosphatidylinositol 3 Kinase Signaling

Aubin, 2005, Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture, Int J Obes (Lond), 29, 1006, 10.1038/sj.ijo.0802961 Engelman, 2006, The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism, Nat. Rev. Genet., 7, 606, 10.1038/nrg1879 Ueki, 2003, Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling, J. Biol. Chem., 278, 48453, 10.1074/jbc.M305602200 Miki, 2001, Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation, Mol. Cell. Biol., 21, 2521, 10.1128/MCB.21.7.2521-2532.2001 Taniguchi, 2006, Critical nodes in signalling pathways: insights into insulin action, Nat. Rev. Mol. Cell Biol., 7, 85, 10.1038/nrm1837 Yu, 2008, Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells, Mol. Cell. Biochem., 310, 11, 10.1007/s11010-007-9661-9 Pal, 2012, PTEN mutations as a cause of constitutive insulin sensitivity and obesity, N. Engl. J. Med., 367, 1002, 10.1056/NEJMoa1113966 Hussain, 2011, An activating mutation of AKT2 and human hypoglycemia, Science, 334, 474, 10.1126/science.1210878 Rivière, 2012, De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes, Nat. Genet., 44, 934, 10.1038/ng.2331 Rodon, 2013, Development of PI3K inhibitors: lessons learned from early clinical trials, Nat Rev Clin Oncol, 10, 143, 10.1038/nrclinonc.2013.10 Aarskog, 1983, Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes, Am. J. Med. Genet., 15, 29, 10.1002/ajmg.1320150104 Koenig, 2003, SHORT syndrome, Clin. Dysmorphol., 12, 45, 10.1097/00019605-200301000-00008 Johansson, 2012, Exome sequencing and genetic testing for MODY, PLoS ONE, 7, e38050, 10.1371/journal.pone.0038050 Winnay, 2010, A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response, Nat. Med., 16, 438, 10.1038/nm.2121 Ueki, 2000, Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit, Mol. Cell. Biol., 20, 8035, 10.1128/MCB.20.21.8035-8046.2000 Klein, 1999, beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes, J. Biol. Chem., 274, 34795, 10.1074/jbc.274.49.34795 Garg, 2004, Acquired and inherited lipodystrophies, N. Engl. J. Med., 350, 1220, 10.1056/NEJMra025261 Fiorenza, 2011, Lipodystrophy: pathophysiology and advances in treatment, Nat Rev Endocrinol, 7, 137, 10.1038/nrendo.2010.199 Garg, 2011, Clinical review#: Lipodystrophies: genetic and acquired body fat disorders, J. Clin. Endocrinol. Metab., 96, 3313, 10.1210/jc.2011-1159 Gorlin, 1975, Malformation syndromes. A selected miscellany, Birth Defects Orig. Artic. Ser., 11, 39 Marengere, 1994, Structure and function of SH2 domains, J. Cell Sci. Suppl., 18, 97, 10.1242/jcs.1994.Supplement_18.14 Songyang, 1993, SH2 domains recognize specific phosphopeptide sequences, Cell, 72, 767, 10.1016/0092-8674(93)90404-E Lappalainen, 2008, Genome wide analysis of pathogenic SH2 domain mutations, Proteins, 72, 779, 10.1002/prot.21970 Waksman, 1993, Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms, Cell, 72, 779, 10.1016/0092-8674(93)90405-F Dupuis, 2010, New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk, Nat. Genet., 42, 105, 10.1038/ng.520 Pereira, 2005, Inhibition of the phosphatidylinositol 3′-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes, Metabolism, 54, 1636, 10.1016/j.metabol.2005.07.002